tiprankstipranks
CytoDyn (CYDY)
OTHER OTC:CYDY

CytoDyn (CYDY) Financial Statements

613 Followers

CytoDyn Financial Overview

CytoDyn's market cap is currently ―. The company's EPS TTM is $-0.061; its P/E ratio is -2.72; CytoDyn is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Nov 23Aug 23May 23Feb 23Nov 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit----$ 0.00
EBIT$ -5.95M$ -7.46M$ 5.29M$ -5.64M$ -24.76M
EBITDA$ -5.80M$ -6.69M$ 15.40M$ -5.05M$ -24.70M
Net Income Common Stockholders$ -9.56M$ -11.57M$ -18.64M$ -13.70M$ -28.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 147.00K$ 2.03M$ 9.05M$ 11.11M$ 2.40M
Total Assets$ 9.24M$ 12.41M$ 11.29M$ 14.64M$ 7.07M
Total Debt$ 33.13M$ 33.35M$ 35.41M$ 36.33M$ 37.28M
Net Debt$ 32.98M$ 31.31M$ 26.37M$ 25.22M$ 34.88M
Total Liabilities$ 123.62M$ 129.30M$ 120.79M$ 121.65M$ 123.04M
Stockholders Equity$ -114.38M$ -116.89M$ -109.50M$ -107.01M$ -115.97M
Cash Flow-
Free Cash Flow$ -2.50M$ -4.50M$ -3.41M$ -6.22M$ -4.41M
Operating Cash Flow$ -2.50M$ -4.50M$ -3.41M$ -6.22M$ -4.41M
Investing Cash Flow----$ 0.00
Financing Cash Flow$ 654.00K$ 4.02M$ 1.35M$ 14.72M$ 2.33M
Currency in USD

CytoDyn Earnings and Revenue History

CytoDyn Debt to Assets

CytoDyn Cash Flow

CytoDyn Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis